BioWorld MedTech

Nov. 15, 2012

The MDD Interview: Chronic disease management cited as key market for VitalSims

Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes. Read More

Guided Therapeutics submits amended PMA for LuViva

Regional innovation review: Diverse range of medical device companies dot Atlanta's landscape

Washington roundup: Nexon: Failure 'not an option' for medical device tax repeal

Agreements/contracts: CPAC set to deliver DWA proton therapy system

Financings roundup: U.S. Bank closes two credit facilities for Trinity Health

Report from Europe: Stryker Ireland cancels plan to eliminate 142 jobs in 2013

Patent watch: T2 Biosystems expands IP with two new U.S. patents

New ventures: RVM forms new division of vascular access centers

Mindray initiates voluntary recall for anesthesia system

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld Science

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

Science in 2025: the best of the rest

BioWorld Science

A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.